詳細信息
- ;3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-d]嘧啶-4-基)氨基)哌啶-1-基)-3-氧代丙腈;CP 690550;CP-690550;3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并(2,3-d)嘧啶-4-基)氨基)哌啶-1-基)-3-氧代丙腈;托法替布;
- Tofacitinib
- ;3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile;3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile;3-{(3S,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile;CP 690550;CP-690550;3-((3r,4r)-4-methyl-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile;
- InChI=1/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13-/m1/s1
- 1.296g/cm3
- 585.845°C at 760 mmHg
- 308.108°C
- 99%
- CAS NO:477600-75-2
產(chǎn)品規(guī)格:98.5%
免責(zé)聲明:以上所展示的信息由企業(yè)自行提供,內(nèi)容的真實性、準確性和合法性由發(fā)布企業(yè)負責(zé),化工網(wǎng)對此不承擔(dān)任何保證責(zé)任。我們原則上建議您選擇化工網(wǎng)高級會員或VIP會員。